Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients - Nature
- ️Downward, Julian
- ️Thu Apr 23 1992
- Letter
- Published: 23 April 1992
Nature volume 356, pages 713–715 (1992)Cite this article
-
1158 Accesses
-
592 Citations
-
11 Altmetric
Abstract
DEFECTS in the NF1 gene have been implicated in the inherited disorder neurofibromatosis type 1, which is characterized by several developmental abnormalities including an increased frequency of benign and malignant tumours of neural crest origin (neuro-fibromas and neurofibrosarcomas respectively)1. The NF1 gene encodes a ubiquitous protein homologous to p!20GAP, the GTPase-activating protein (GAP) for the products of the ras proto-oncogenes2–6. When expressed in non-mammalian systems, the region of the NF1 gene homologous to p!20GAP produces a protein with GAP-like activity7–9. Here we present evidence that the ras proteins in malignant tumour cell lines from patients with type 1 neurofibromatosis are in a constitutively activated state, as judged by the guanine nucleotide bound to them, and are necessary for cellular proliferation. These cells contain P21rasand p120GAP that are both functionally wild type, but barely any functional NF1 protein. Our results show that the NF1 protein is normally essential for correct negative regulation of ras proteins in the cell, even in the presence of normal p120GAP, and they support the hypothesis that NF1 is a tumour-suppressor gene whose product acts upstream of ras.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
References
Riccardi, V. & Eichner, J. Neurofibromatosis: Phenotype, Natural History and Pathogenesis (Johns Hopkins Univ. Press, Baltimore, 1986).
Viskochil, D. et al. Cell 62, 187–192 (1990).
Cawthorn, R. M. et al. Cell 62, 193–201 (1990).
Wallace, M. R. et al. Science 249, 181–186 (1990).
Xu, G. et al. Cell 62, 599–608 (1990).
Buchberg, A. M., Cleveland, L. S., Jenkins, N. A. & Copeland, N. G. Nature 347, 291–294 (1990).
Xu, G. et al. Cell 63, 835–841 (1990).
Martin, G. A. et al. Cell 63, 843–849 (1990).
Ballester, R. et al. Cell 63, 851–859 (1990).
Downward, J. Curr. Opin. dev. Genet. 2, 13–18 (1992).
Downward, J., Graves, J. D., Warne, P. H., Rayter, S. & Cantrell, D. A. Nature 346, 719–723 (1990).
Hattori, S. et al. Biochem. biophys. Res. Commun. 177, 83–89 (1991).
Gutmann, D. H., Wood, D. L. & Collins, F. S. Proc. natn. Acad. Sci. U.S.A. 88, 9658–9662 (1991).
Fletcher, J. A. et al. New Engl. J. Med. 324, 436–443 (1991).
Glover, T. W. et al. Genes, Chromosomes Cancer 3, 62–70 (1991).
Nigro, J. M. et al. Nature 342, 705–708 (1989).
Ridley, A. J., Paterson, H. F., Noble, M. & Land, H. EMBO J. 7, 1635–1645 (1988).
Menon, A. G. et al. Proc. natn. Acad. Sci. U.S.A. 87, 5435–5439 (1990).
Downward, J., de Gunzburg, J., Riehl, R. & Weinberg, R. A. Proc. natn. Acad. Sci. U.S.A. 85, 5774–5778 (1988).
Cantrell, D. A., Collins, M. K. & Crumpton, M. J. Immunology 65, 343–349 (1988).
Harlow, E. & Lane, D. Antibodies: a Laboratory Manual (Cold Spring Harbor Laboratory, New York, 1988).
Smith, M. R., DeGudicubus, S. J. & Stacey, D. W. Nature 320, 540–543 (1986).
Author information
Author notes
Julian Downward: To whom correspondence should be addressed
Authors and Affiliations
Signal Transduction Laboratory, Imperial Cancer Research Fund, Lincoln's Inn Fields, London, WC2A 3PX, UK
Tanya N. Basu & Julian Downward
Howard Hughes Medical Institute and Departments of Internal Medicine and Human Genetics, University of Michigan Medical School, Ann Arbor, Michigan, 48109, USA
David H. Gutmann & Francis S. Collins
Department of Pathology, Brigham and Women's Hospital, 75 Francis Street, Boston, Massachusetts, 02115, USA
Jonathan A. Fletcher
Departments of Pediatrics and Human Genetics, University of Michigan Medical School, Ann Arbor, Michigan, 48109, USA
Thomas W. Glover
Authors
- Tanya N. Basu
You can also search for this author in PubMed Google Scholar
- David H. Gutmann
You can also search for this author in PubMed Google Scholar
- Jonathan A. Fletcher
You can also search for this author in PubMed Google Scholar
- Thomas W. Glover
You can also search for this author in PubMed Google Scholar
- Francis S. Collins
You can also search for this author in PubMed Google Scholar
- Julian Downward
You can also search for this author in PubMed Google Scholar
Rights and permissions
About this article
Cite this article
Basu, T., Gutmann, D., Fletcher, J. et al. Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. Nature 356, 713–715 (1992). https://doi.org/10.1038/356713a0
Received: 10 January 1992
Accepted: 06 March 1992
Issue Date: 23 April 1992
DOI: https://doi.org/10.1038/356713a0